[HTML][HTML] Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric …

P Tétu, C Allayous, B Oriano, S Dalle, L Mortier… - European Journal of …, 2019 - Elsevier
Abstract Background Melanoma brain metastases (MBMs) are historically associated with
poor prognosis. Radiation therapy is conventionally associated with a high local control rate …

Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric …

P Tétu, C Allayous, B Oriano, S Dalle… - European Journal of …, 2019 - europepmc.org
BACKGROUND: Melanoma brain metastases (MBMs) are historically associated with poor
prognosis. Radiation therapy is conventionally associated with a high local control rate …

Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric …

P Tétu, C Allayous, B Oriano, S Dalle… - … journal of cancer …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Melanoma brain metastases (MBMs) are historically associated with poor
prognosis. Radiation therapy is conventionally associated with a high local control rate …

Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric …

P Tétu, C Allayous, B Oriano, S Dalle… - European Journal of …, 2019 - ejcancer.com
Abstract Background Melanoma brain metastases (MBMs) are historically associated with
poor prognosis. Radiation therapy is conventionally associated with a high local control rate …

Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric …

P Tétu, C Allayous, B Oriano, S Dalle… - European Journal of …, 2019 - hal.science
Background: Melanoma brain metastases (MBMs) are historically associated with poor
prognosis. Radiation therapy is conventionally associated with a high local control rate …

[PDF][PDF] Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric …

P Tétu, C Allayous, B Oriano, S Dalle, L Mortier… - 2019 - academia.edu
2 personal fees and other from Novartis, outside the submitted work. 43 Dr. Dutriaux reports
personal fees and other from Amgen, personal fees and other from 44 Novartis, personal …

Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric …

P Tétu, C Allayous, B Oriano, S Dalle… - European Journal of …, 2019 - ejcancer.com
Abstract Background Melanoma brain metastases (MBMs) are historically associated with
poor prognosis. Radiation therapy is conventionally associated with a high local control rate …